BioCryst Pharmaceuticals | BCRX - Stock


BioCryst Pharmaceuticals reported $5.23M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
BioCryst Pharmaceuticals USD 5.23M 188K Sep/2025
Chugai Pharma JPY 246.33B 10.8B Sep/2025
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novavax USD 13.51M 3.27M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025